← Eichor
Study identifier: NCT07588087 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Adding Latissimus Dorsi Myofascial Release to Scapular Proprioceptive Neuromuscular Facilitation on Pain, Disability, and Range of Motion in Adhesive Capsulitis

Condition: Adhesive Capsulitis  ·  Sponsor: Ibadat International University, Islamabad

PhaseNA
Planned participants58
Who can joinAll sexes, 35 Years to 70 Years
Healthy volunteersNo

About this study

This randomized controlled trial aims to compare the effects of scapular proprioceptive neuromuscular facilitation (PNF) alone versus PNF combined with latissimus dorsi myofascial release on pain, range of motion, and functional disability in patients with stage II adhesive capsulitis; a condition characterized by capsular stiffness, pain, and restricted shoulder mobility, with outcomes assessed using NPRS, goniometry, and SPADI over a 6-week intervention period.

This description comes directly from the study's public registry record.

Talk to the study team

Hufsa Naseer, DPT, MS-PT MSK  ·  +3095166821  ·  hufsanaseer@gmail.com

Fatima Amjad, DPT, MS-PT Sports, PHD Scholar  ·  +3330940975  ·  Fatima.amjad@uipt.iiui.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

• Ibadat international hospital • Shaafi international hospital • South East hospital • Fauji Foundation hospitalIslamabad, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07588087